This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2008 May;197(4):687-8.

doi: 10.1007/s00213-008-1091-1. Epub 2008 Feb 10.

Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder

Rahul Sarkar, Julia Klein, Stephanie Krüger

PMID: 18264798
DOI: 10.1007/s00213-008-1091-1

Case Reports

Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder

Rahul Sarkar et al. Psychopharmacology (Berl). 2008 May.

. 2008 May;197(4):687-8.

doi: 10.1007/s00213-008-1091-1. Epub 2008 Feb 10.

Authors

Rahul Sarkar, Julia Klein, Stephanie Krüger

PMID: 18264798
DOI: 10.1007/s00213-008-1091-1

No abstract available

PubMed Disclaimer

Similar articles

Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
Storch EA, Lehmkuhl H, Geffken GR, Touchton A, Murphy TK. Storch EA, et al. Depress Anxiety. 2008;25(2):172-4. doi: 10.1002/da.20303. Depress Anxiety. 2008. PMID: 17340610
Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study.
Ak M, Bulut SD, Bozkurt A, Ozsahin A. Ak M, et al. Adv Ther. 2011 Apr;28(4):341-8. doi: 10.1007/s12325-011-0011-7. Epub 2011 Mar 21. Adv Ther. 2011. PMID: 21437763 Clinical Trial.
The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study.
Selvi Y, Atli A, Aydin A, Besiroglu L, Ozdemir P, Ozdemir O. Selvi Y, et al. Hum Psychopharmacol. 2011 Jan;26(1):51-7. doi: 10.1002/hup.1169. Hum Psychopharmacol. 2011. PMID: 21308781 Clinical Trial.
Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.
Dold M, Aigner M, Lanzenberger R, Kasper S. Dold M, et al. Int J Neuropsychopharmacol. 2013 Apr;16(3):557-74. doi: 10.1017/S1461145712000740. Epub 2012 Aug 29. Int J Neuropsychopharmacol. 2013. PMID: 22932229 Review.
Pharmacological management of obsessive-compulsive disorder: a review for clinicians.
McDonough M, Kennedy N. McDonough M, et al. Harv Rev Psychiatry. 2002 May-Jun;10(3):127-37. doi: 10.1080/10673220216215. Harv Rev Psychiatry. 2002. PMID: 12023928 Review.

See all similar articles

Cited by

Obsessive-Compulsive Disorder Presenting with Compulsions to Urinate Frequently.
Jiwanmall SA, Kattula D. Jiwanmall SA, et al. Indian J Psychol Med. 2016 Jul-Aug;38(4):364-5. doi: 10.4103/0253-7176.185953. Indian J Psychol Med. 2016. PMID: 27570353 Free PMC article.
Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report.
Fornaro M, Gabrielli F, Mattei C, Vinciguerra V, Fornaro P. Fornaro M, et al. Ann Gen Psychiatry. 2008 Dec 23;7:26. doi: 10.1186/1744-859X-7-26. Ann Gen Psychiatry. 2008. PMID: 19105842 Free PMC article.
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
Del Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis DA, Rapinesi C, Sani G, Girardi P, Kotzalidis GD, Pompili M. Del Casale A, et al. Curr Neuropharmacol. 2019;17(8):710-736. doi: 10.2174/1570159X16666180813155017. Curr Neuropharmacol. 2019. PMID: 30101713 Free PMC article. Review.
Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.
Kim D, Ryba NL, Kalabalik J, Westrich L. Kim D, et al. Drugs R D. 2018 Sep;18(3):167-189. doi: 10.1007/s40268-018-0246-8. Drugs R D. 2018. PMID: 30171515 Free PMC article. Review.
Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder.
Uzun O, Ozdemir B. Uzun O, et al. Clin Drug Investig. 2010;30(10):707-10. doi: 10.2165/11536730-000000000-00000. Clin Drug Investig. 2010. PMID: 20701402

See all "Cited by" articles

References

1. J Clin Psychiatry. 2004;65 Suppl 14:11-7 - PubMed
1. Drugs. 2004;64(15):1715-36 - PubMed
1. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1550-1 - PubMed
1. Arch Gen Psychiatry. 2000 Aug;57(8):794-801 - PubMed
1. J Child Neurol. 2005 Jul;20(7):603-10 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information